Publications
232 results found
Rutebemberwa A, Auma B, Gilmour J, et al., 2004, HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected Ugandans, AIDS Res Hum Retroviruses, Vol: 20, Pages: 763-771, ISSN: 0889-2229
Huang A, Gilmour JW, Imami N, et al., 2003, Increased serum transforming growth factor-beta1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration, Clin Exp Immunol, Vol: 134, Pages: 270-278, ISSN: 0009-9104
Patterson S, Rae A, Hockey N, et al., 2001, Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus, J Virol, Vol: 75, Pages: 6710-6713, ISSN: 0022-538X
Donaghy H, Pozniak A, Gazzard B, et al., 2001, Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load, Blood, Vol: 98, Pages: 2574-2576, ISSN: 0006-4971
Michie CA, Gilmour J, 2001, Breast feeding and the risks of viral transmission, Arch Dis Child, Vol: 84, Pages: 381-382, ISSN: 1468-2044
Gilmour JW, Gilling-Smith C, Gotch F, 2001, Reduction of HIV transmission in HIV-discordant couples wishing to conceive, AIDS, Vol: 15, Pages: 429-430, ISSN: 0269-9370
Morgan D, Kaleebu P, Whitworth J, et al., 2001, The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural Uganda, Int J STD AIDS, Vol: 12, Pages: 116-121, ISSN: 0956-4624
Jones GJ, Watera C, Patterson S, et al., 2001, Comparative loss and maturation of peripheral blood dendritic cell subpopulations in African and non-African HIV-1-infected patients, AIDS, Vol: 15, Pages: 1657-1663, ISSN: 0269-9370
Michie C, Gilmour J, Riddell A, et al., 2000, Activation of dendritic cells corresponds with the outcome in congenital parvovirus infection, Publisher: INT PEDIATRIC RESEARCH FOUNDATION, INC, Pages: 271A-271A, ISSN: 0031-3998
Tucker V, Jenkins J, Gilmour J, et al., 2000, T-cell telomere length maintained in HIV-infected long-term survivors, HIV Med, Vol: 1, Pages: 116-122, ISSN: 1464-2662
Michie CA, Gilmour JW, 2000, Breastfeeding and viral transmission: risks, benefits and treatments, J Trop Pediatr, Vol: 46, Pages: 256-257, ISSN: 0142-6338
Gotch F, Rutebemberwa A, Jones G, et al., 2000, Vaccines for the control of HIV/AIDS, Trop Med Int Health, Vol: 5, Pages: A16-A21, ISSN: 1360-2276
This review discusses the feasibility of an HIV vaccine and describes the history, efficacy and potential to succeed of old and new vaccine concepts.
Gilmour JW, Patterson S, 1999, Dendritic cells in HIV disease and treatment, J HIV Therapy, Vol: 4, Pages: 102-106
Kim LU, Johnson MR, Barton S, et al., 1999, Evaluation of sperm washing as a potential method of reducing HIV transmission in HIV-discordant couples wishing to have children, AIDS, Vol: 13, Pages: 645-651, ISSN: 0269-9370
Gilmour J, Helbert M, Patterson S, et al., 1996, Maturation of Blood Dendritic Cells in HIV Infection
Norval M, Gibbs NK, Gilmour J, 1995, The role of urocanic acid in UV-induced immunosuppression: recent advances (1992-1994), Photochem Photobiol, Vol: 62, Pages: 209-217, ISSN: 0031-8655
Cis-urocanic acid (UCA), formed in the epidermis by UV irradiation of trans-UCA, has been implicated as a mediator of the immunosuppression induced by UV exposure of the skin. This review covers recent work in which the wavelength dependence of cis-UCA formation, the interaction of UCA isomers with DNA, the effects of UCA isomers on the immune system and their interaction with histamine are examined. Results are frequently conflicting, particularly when considering the possible mode of action of cis-UCA but, overall, a multifaceted role for UCA in immunomodulation by UV radiation is substantiated.
KNIGHT SC, GILMOUR J, REID C, et al., 1995, HIV-1 INFECTION OF DENDRITIC CELLS (DC) DERIVED FROM BONE-MARROW STEM-CELLS, Publisher: MARY ANN LIEBERT INC PUBL, Pages: S90-S90, ISSN: 0889-2229
- Author Web Link
- Cite
- Citations: 3
DEKOSSODO S, GILMOUR J, DOUGHERTY I, et al., 1994, ULTRAVIOLET-B (UVB) RADIATION AND UROCANIC ACID (UCA) EXHIBIT DIVERGENT EFFECTS ON TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) GENE ACTIVATION, Publisher: BLACKWELL SCIENCE INC, Pages: 539-539, ISSN: 0022-202X
- Author Web Link
- Cite
- Citations: 3
DEKOSSODO S, GILMOUR J, DOUGHERTY I, et al., 1993, DIVERGENT EFFECTS OF UVB RADIATION AND UROCANIC ACID (UCA) ON TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) GENE ACTIVATION, Publisher: SLACK INC, Pages: A743-A743, ISSN: 0009-9279
Gilmour J, Norval M, Simpson TJ, 1993, Der effect der UV-therapie auf die immunfunktion von psoriasispatienten, Zeitschrift fur Haut-Krankheiten, Vol: 68, Pages: 466-475
Norval M, Gilmour JW, Simpson TJ, 1990, The effect of histamine receptor antagonists on immunosuppression induced by the cis-isomer of urocanic acid, Photodermatol Photoimmunol Photomed, Vol: 7, Pages: 243-248, ISSN: 0905-4383
Gilmour JA, 1989, Accreditation of Medical Laboratories in Australia, Pages: 110-115, ISSN: 0066-0558
Medical laboratories in Australia are required to be accredited by either the Commonwealth government or by one of the state governments. Arrangements vary from state to state but almost all rely on an on-site assessment conducted by the National Association of Testing Authorities, Australia (NATA) in collaboration with the Royal College of Pathologists of Australasia (RCPA). This paper describes the background to this system and outlines the complementary roles of the various organizations involved. Some information is also provided on criteria development, selection and training of assessors, and the assessment process as employed by NATA. The role of proficiency testing programs operated by bodies such as RCPA, Wellcome Laboratories, and the College of American Pathologists is also mentioned. The system has been operational since 1983, and over 100 separate laboratories representing approximately 300 laboratory units have been accredited. This paper comments on the outcome of those assessments.
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.